Strategic Blueprint, LLC Silk Road Medical Inc Transaction History

Strategic Blueprint, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$28.03 - $45.8 $147,521 - $241,045	-5,263 Closed	0 $0
Q1 2022 Aug 12, 2022	SELL	$29.24 - $44.06 $62,222 - $93,759	-2,128 Reduced 28.79%	5,263 $217,000
Q3 2020 Oct 27, 2020	BUY	$42.19 - $69.61 $33,203 - $54,783	787 Added 11.92%	7,391 $497,000
Q1 2020 Apr 20, 2020	SELL	$23.16 - $47.8 $172,032 - $355,058	-7,428 Reduced 52.94%	6,604 $208,000
Q4 2019 Jan 10, 2020	BUY	$27.97 - $40.38 $392,475 - $566,612	14,032 New	14,032 $567,000

180

37.9M

148K

205K

Ticker SILK
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,565,600
Market Cap $1.03B
Description
Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate te...

Get notified when there are updates to the investment portfolio of Strategic Blueprint, LLC, based on Form 13F filings with the SEC.

Stay updated on Strategic Blueprint, LLC with notifications on news.